MARKET

DVA

DVA

Davita Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

95.42
+2.01
+2.15%
After Hours: 95.42 0 0.00% 16:15 05/25 EDT
OPEN
93.42
PREV CLOSE
93.41
HIGH
96.93
LOW
92.73
VOLUME
721.16K
TURNOVER
0
52 WEEK HIGH
136.48
52 WEEK LOW
91.73
MARKET CAP
9.03B
P/E (TTM)
11.35
1D
5D
1M
3M
1Y
5Y
DaVita's Return on Invested Capital Overview
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters.
Benzinga · 9h ago
Stocks That Hit 52-Week Lows On Monday
  On Monday, 149 companies reached new 52-week lows.
Benzinga · 2d ago
These Are The Top 8 Stocks To Own In A Bear Market
The dreaded S&P 500 bear is nearly here. But don't think you need to hibernate to make money in a rough market.
Investor's Business Daily · 2d ago
Reasons to Retain DaVita (DVA) Stock in Your Portfolio For Now
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Zacks · 5d ago
Glenview Capital added Valvoline, exited Amgen, expanded position in US Foods, narrowed stake in Bausch Health
Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline (VVV) with 1.7M shares, Berkeley Lights (BLI) with 1.19M shares,
Seekingalpha · 05/17 14:41
Most likely large-cap and small-cap merger candidates -BofA
BofA Securities screened for stocks with the the characteristics most likely to attract suitors, both in the large- and small-cap universes. For S&P 500 (SP500) (SPY) targets, BofA: Screens based
Seekingalpha · 05/15 15:42
Markets Finish Sharply Higher Amid Ongoing Macro Concerns
U.S. indices traded sharply higher Friday following recent weakness. Markets were highly volatile this week, selling off following the April CPI report, which showed worse-than-expected inflation.
Benzinga · 05/13 20:07
DaVita Honors Extraordinary Nurses with DAISY Awards
DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of the DAISY Foundation's™ mission to recognize the outstanding, compassionate care that nurs...
PR Newswire · 05/10 10:02
More
No Data
Learn about the latest financial forecast of DVA. Analyze the recent business situations of Davita Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
22.22%Buy
55.56%Hold
22.22%Under-perform
0.00%Sell
Analyst Price Target
The average DVA stock price target is 121.88 with a high estimate of 150.00 and a low estimate of 109.00.
High150.00
Average121.88
Low109.00
Current 95.42
EPS
Actual
Estimate
0.661.321.982.64
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 727
Institutional Holdings: 108.78M
% Owned: 114.99%
Shares Outstanding: 94.60M
TypeInstitutionsShares
Increased
128
1.98M
New
73
971.93K
Decreased
208
6.63M
Sold Out
84
1.10M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.72%
Healthcare Providers & Services
+0.26%
Key Executives
Non-Executive Chairman/Independent Director
Pamela Arway
Chief Executive Officer/Director
Javier Rodriguez
Chief Financial Officer/Treasurer
Joel Ackerman
Chief Accounting Officer
John Winstel
Chief Compliance Officer
James Hearty
Other
Mihran Naljayan
Other
Michael Staffieri
Other
Kathleen Waters
Director
Charles Berg
Independent Director
Barbara Desoer
Independent Director
Paul Diaz
Independent Director
Jason Hollar
Independent Director
Gregory Moore
Independent Director
John Nehra
Independent Director
Paula Price
Independent Director
Phyllis Yale
No Data
No Data
About DVA
DaVita Inc. is a healthcare provider focused on providing kidney care services. The Company's principal business is to provide dialysis and related lab services to patients. It is engaged in providing care delivery, referred to as United States (U.S.) dialysis business. The Company also operate various ancillary services, including its international operations, as well as its corporate administrative support. Its U.S. dialysis business is a provider of kidney dialysis services for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD). The Company's ancillary services consist primarily of integrated care and disease management, clinical research programs and physician services, as well as its international operations. The Company's international dialysis operations provides dialysis and administrative services through a total of 333 outpatient dialysis centers located in ten countries outside of the United States.

Webull offers kinds of Davita Inc stock information, including NYSE:DVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DVA stock methods without spending real money on the virtual paper trading platform.